
Investing.com – Israel stocks were higher after the close on Sunday, as gains in the Biomed, Insurance and Technology sectors led shares higher.
At the close in Tel Aviv, the TA 35 gained 0.81% to hit a new 52-week high.
The best performers of the session on the TA 35 were Nova (TASE:NVMI), which rose 7.45% or 4,530.00 points to trade at 65,330.00 at the close. Meanwhile, Teva Pharmaceutical Industries Ltd (TASE:TEVA) added 2.58% or 121.00 points to end at 4,820.00 and Shikun&Binui (TASE:SKBN) was up 2.35% or 23.00 points to 979.00 in late trade.
The worst performers of the session were Mizrahi Tefahot (TASE:MZTF), which fell 1.98% or 280.00 points to trade at 13,850.00 at the close. Energean Oil&Gas PLC (TASE:ENOG) declined 1.08% or 52.00 points to end at 4,748.00 and Energix (TASE:ENRG) was down 0.97% or 13.00 points to 1,326.00.
Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 299 to 162 and 75 ended unchanged.
Shares in Nova (TASE:NVMI) rose to all time highs; gaining 7.45% or 4,530.00 to 65,330.00.
Crude oil for April delivery was up 1.98% or 1.55 to $79.81 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May rose 1.89% or 1.55 to hit $83.46 a barrel, while the April Gold Futures contract rose 1.80% or 36.90 to trade at $2,091.60 a troy ounce.
USD/ILS was down 0.18% to 3.56, while EUR/ILS rose 0.13% to 3.86.
The US Dollar Index Futures was down 0.26% at 103.82.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.